MAZHAR, FAIZAN
MAZHAR, FAIZAN
Dipartimento di Scienze Biomediche e Cliniche
EXPLOITING DIVERSE DATA SOURCES TO INVESTIGATE EMERGING SAFETY ISSUES OF DRUGS IN POST-MARKETING PHASE: A RESEARCH FRAMEWORK FOR CLINICAL PHARMACOLOGIST
2021 F. Mazhar
Inflammasome Targeted Therapy in Pregnancy: New Insights From an Analysis of Real-World Data From the FAERS Database and a Systematic Review
2021 C. Carnovale, E. Tombetti, V. Battini, F. Mazhar, S. Radice, M. Nivuori, E. Negro, S. Tamanini, A. Brucato
β-blockers associated hypoglycaemia: new insights from a real-world pharmacovigilance study [Beta-blocker-associated hypoglycaemia: New insights from a real-world pharmacovigilance study]
2021 C. Carnovale, M. Gringeri, V. Battini, G. Mosini, E. Invernizzi, F. Mazhar, F. Bergamaschi, M. Fumagalli, G.V. Zuccotti, E.G.I. Clementi, S. Radice, V. Fabiano
Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: A network meta-analysis and regression
2021 C. Carnovale, E. Lucenteforte, V. Battini, F. Mazhar, M. Fornili, E. Invernizzi, G. Mosini, M. Gringeri, A. Capuano, C. Scavone, M. Nobile, C. Vantaggiato, S. Pisano, C. Bravaccio, S. Radice, E. Clementi, M. Pozzi
Finding Early Improvement Threshold to Predict Response After 8 Weeks of Treatment Using Risperidone in First-Episode Psychosis
2021 V. Subeesh, E. Maheswari, H. Singh, R. Neha, F. Mazhar
The impact of anti-TNFα agents on weight-related changes : new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database
2021 F. Mazhar, V. Battini, M. Gringeri, M. Pozzi, G. Mosini, A.M.N. Marran, S. Akram, R.P. van Manen, S. Radice, E. Clementi, C. Carnovale
Antiemetic Drugs during Pregnancy : What Can We Learn from Spontaneous Reporting System Database Analyses?
2021 F. Mazhar, V. Battini, C. Carnovale
Severe burn injury: Body Mass Index and the Baux score
2021 G.H. Saadat, R. Toor, F. Mazhar, F. Bajani, L. Tatebe, V. Schlanser, M. Kaminsky, T. Messer, F. Starr, A. Dennis, S. Poulakidas, F. Bokhari
Hyponatremia Following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports From the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review
2021 F. Mazhar, V. Battini, M. Pozzi, E. Invernizzi, G. Mosini, M. Gringeri, A. Capuano, C. Scavone, S. Radice, E. Clementi, C. Carnovale
Health-related quality of life and its predictors among adults living with HIV/AIDS and receiving antiretroviral therapy in Pakistan
2021 A. Ahmed, M. Saqlain, N. Bashir, J. Dujaili, F. Hashmi, F. Mazhar, A. Khan, M. Jabeen, A. Blebil, A. Awaisu
Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
2020 F. Mazhar, M.A. Hadi, C.S. Kow, A.M.N. Marran, H.A. Merchant, S.S. Hasan
Paliperidone-Associated Hyponatremia: Report of a Fatal Case with Analysis of Cases Reported in the Literature and to the US Food and Drug Administration Adverse Event Reporting System
2020 F. Mazhar, C. Carnovale, N. Haider, R. Ahmed, M. Taha
Potentially inappropriate medications use and its association with health-related quality of life among elderly cardiac patients
2020 M. Saqlain, H. Ali, S. Kamran, M.U. Munir, S. Jahan, F. Mazhar
Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
2020 F. Mazhar, V. Battini, M. Pozzi, E. Invernizzi, G. Mosini, M. Gringeri, A. Capuano, C. Scavone, S. Radice, E. Clementi, C. Carnovale
Are dizziness-related symptoms signals for suboptimal treatment of hypothyroidism? New insights from the FDA adverse event reporting system (FAERS) database
2020 C. Carnovale, V. Battini, F. Mazhar, G. Mosini, M. Gringeri, A. Vicenzi, E. Clementi, S. Radice
Efficacy of Tumour Necrosis Factor-alpha therapy in paediatric Crohn’s disease patients with perianal lesions: a systematic review
2020 C. Carnovale, A. Maffioli, G. Zaffaroni, F. Mazhar, V. Battini, G. Mosini, M. Pozzi, S. Radice, E. Clementi, P. Danelli
Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis
2020 S.S. Hasan, T. Capstick, R. Ahmed, C.S. Kow, F. Mazhar, H.A. Merchant, S.T.R. Zaidi
The β-cell effect of verapamil-based treatment in patients with type 2 diabetes: a systematic review
2019 C. Carnovale, A. Dassano, G. Mosini, F. Mazhar, F. D'Addio, M. Pozzi, S. Radice, P. Fiorina, E. Clementi
Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance-Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
2019 F. Mazhar, M. Pozzi, M. Gentili, M. Scatigna, E. Clementi, S. Radice, C. Carnovale
A systematic review of the antidepressant effects of glucagon-like peptide 1 (GLP-1) functional agonists: Further link between metabolism and psychopathology
2019 M. Pozzi, F. Mazhar, G.G.A.M. Peeters, C. Vantaggiato, M. Nobile, E. Clementi, S. Radice, C. Carnovale